Skip to content
Screener

Cue Biopharma CUE Q2 2026 earnings

Reported August 14, 2026 · After market close

Revenue$7.9MBeat by $4.9M
EPS-$24.14Miss by $22.45
Revenue estimate$3.0M
EPS estimate-$1.69

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$1.0M
EPS estimate-$2.24

FAQ

When did Cue Biopharma report Q2 2026 earnings?
Cue Biopharma (CUE) reported Q2 2026 earnings on August 14, 2026 after market close.
What were Cue Biopharma's Q2 2026 revenue and EPS?
Cue Biopharma reported revenue of $7.9M and eps of $-24.14 for Q2 2026.
Did Cue Biopharma beat estimates in Q2 2026?
Revenue beat the consensus estimate of $3.0M by $4.9M. EPS missed the consensus estimate of $-1.69 by $22.45.
How did Cue Biopharma's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 166.7% from $3.0M a year earlier and eps declined 26722.2% from $-0.09.
Where can I find Cue Biopharma's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-352126) and the 10-Q periodic report (0001193125-26-352128) directly on SEC EDGAR. The filing index links above go to sec.gov.